BEROTRALSTAT DIHYDROCHLORIDE | N214094 | BIOCRYST PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BioCryst Pharmaceuticals, Inc. v. Annora Pharma Private Limited et al 3 patentsANDA 220116berotralstat dihydrochloride | D. Del. | 2025-03-10 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 10125102 | Apr 7, 2035PED: Oct 7, 2035 | PED | Yes | — | — | |
| 10329260 | Mar 9, 2035PED: Sep 9, 2035 | PED | Yes | — | — | — |
| 10662160 | Nov 1, 2039PED: May 1, 2040 | PED | Yes | — | — | |
| 10689346 | Mar 9, 2035PED: Sep 9, 2035 | PED | — | — | — | |
| 11117867 | Nov 1, 2039PED: May 1, 2040 | PED | — | Yes | — | |
| 11230530 | Mar 9, 2035PED: Sep 9, 2035 | PED | — | — | — | |
| 11618733 | Nov 1, 2039PED: May 1, 2040 | PED | — | — | — | |
| 11708333 | Mar 9, 2035PED: Sep 9, 2035 | PED | — | — | — | |
| 12116346 | Mar 9, 2035PED: Sep 9, 2035 | PED | Yes | — | — | — |
| 12344585 | Nov 1, 2039PED: May 1, 2040 | PED | — | — | — | |
| 12545645 | Nov 1, 2039PED: May 1, 2040 | PED | Yes | Yes | — | — |
| 12545646 | Nov 1, 2039PED: May 1, 2040 | PED | Yes | Yes | — | — |
| 12545647 | Nov 1, 2039PED: May 1, 2040 | PED | Yes | Yes | — | — |
| 12552750 | Nov 1, 2039PED: May 1, 2040 | PED | Yes | Yes | — | — |
| 12590068 | Nov 1, 2039PED: May 1, 2040 | PED | Yes | Yes | — | — |
| 12590069 | Nov 1, 2039PED: May 1, 2040 | PED | Yes | Yes | — | — |
| Code | Date | Status |
|---|---|---|
| ODE-333 | Dec 3, 2027 | Active |
| PED | Jun 3, 2028 | Active |